A METHOD OF PREDICTING RESPONSE TO TREATMENT IN CANCER PATIENTS

    公开(公告)号:WO2020011770A1

    公开(公告)日:2020-01-16

    申请号:PCT/EP2019/068365

    申请日:2019-07-09

    Abstract: A method of predicting response to chemotherapy in a patient with cancer is described. The method comprises the steps of incubating an ADCC-capable molecule, an immune response modulator, a cancer cell line that expresses a target of the ADCC-capable molecule, and a sample of the patient's blood, for a period of time, determining an ADCC response of the cancer cell line, comparing the ADCC response with a reference ADCC response, and predicting the patient's response to chemotherapy based on the comparison. In one aspect, the cancer is a HER2+ cancer, the ADCC-capable molecule is an antibody targeting HER2, and the cancer cell lines is a HER2+ cancer cell line.

    A NAVIGATION DEVICE AND A NAVIGATION COMMUNICATION SYSTEM

    公开(公告)号:WO2019206894A1

    公开(公告)日:2019-10-31

    申请号:PCT/EP2019/060350

    申请日:2019-04-23

    Abstract: The invention provides a navigation device comprising a docking portion configured to securely adhere to a surface and a unit having at least one of a visual, an audio or tactile indicator. The present invention provides a device which the user attaches to a wall or door or ground surface entered on the way into a building. A number of fixed devices then assist the user to retrace their route out of the building. In addition, the device can be configured to transmit essential information to a user located outside the building. The devices can also be configured to form a novel navigation communication system.

    MULTIPROTEASE THERAPEUTICS FOR CHRONIC PAIN
    4.
    发明申请
    MULTIPROTEASE THERAPEUTICS FOR CHRONIC PAIN 审中-公开
    慢性疼痛的多重治疗方法

    公开(公告)号:WO2015097087A1

    公开(公告)日:2015-07-02

    申请号:PCT/EP2014/078732

    申请日:2014-12-19

    Abstract: The invention includes Clostridial neurotoxin derivatives containing at least two light chain endopeptidase domains, and nucleic acids encoding such Clostridial neurotoxin derivatives. In preferred embodiments, the invention includes methods and compositions for the treatment of inflammatory disorders(such as arthritis); chronic pain, such as neuropathic painand inflammatory pain through the use of such Clostridial neurotoxin derivatives, including those derived from an intact BoNT/A having an LC/E- derived endopeptidase joined to the LC/A endopeptidase.

    Abstract translation: 本发明包括含有至少两个轻链内肽酶结构域的梭菌神经毒素衍生物和编码这种梭菌神经毒素衍生物的核酸。 在优选的实施方案中,本发明包括用于治疗炎症性疾病(例如关节炎)的方法和组合物; 包括通过使用这种梭菌神经毒素衍生物的神经性疼痛和炎性疼痛的慢性疼痛,包括衍生自具有连接到LC / A内肽酶的LC / E-衍生内肽酶的完整BoNT / A的那些。

    BIOMOLECULAR LABELS, INVOLVING NANOPARTICLES FUNCTIONALISED WITH DENDRIMERS
    6.
    发明申请
    BIOMOLECULAR LABELS, INVOLVING NANOPARTICLES FUNCTIONALISED WITH DENDRIMERS 审中-公开
    生物分子标记,涉及具有DENDRIMERS功能的纳米粒子

    公开(公告)号:WO2011045394A1

    公开(公告)日:2011-04-21

    申请号:PCT/EP2010/065469

    申请日:2010-10-14

    CPC classification number: B82Y15/00 G01N33/587

    Abstract: A label comprising: a nanoparticle wherein the nanoparticle surface is functionalised to comprise at least one dendrimer having at least one activatable functional group for conjugating a target analyte to the functionalised nanoparticle, wherein the dendrimer has a stabilizing effect on the zeta potential at the nanoparticle surface. Such a label is desirable since the stabilizing effect results from an increase in the zeta potential at the nanoparticle surface. The dendrimer functionalised nanoparticle may be conjugated to a detection molecule which detects a target analyte. Use of the labels in bioassays allow detection of ultralow LODs.

    Abstract translation: 一种标签,包括:纳米颗粒,其中纳米颗粒表面被官能化以包含至少一个具有至少一个可激活官能团的树状聚合物,用于将目标分析物与功能化的纳米颗粒共轭,其中树枝状聚合物对纳米颗粒表面上的ζ电位具有稳定作用 。 这种标签是期望的,因为稳定效应是由纳米颗粒表面的ζ电位的增加引起的。 树枝状大分子官能化纳米颗粒可以与检测目标分析物的检测分子缀合。 在生物测定中使用标签可以检测超低LOD。

Patent Agency Ranking